These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3317170)

  • 1. [Toxicity of the CYVADIC modification in patients with soft tissue sarcomas or malignant mesotheliomas].
    Sauer H; Kremer G; Wilmanns W
    Onkologie; 1987 Oct; 10(5):294-300. PubMed ID: 3317170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of a series of sixty soft tissue sarcomas in adults treated with a cyclophosphamide-vincristine-adriamycin-dacarbazine (CYVADIC) combination.
    Bui NB; Chauvergne J; Hocke C; Durand M; Brunet R; Coindre JM
    Cancer Chemother Pharmacol; 1985; 15(1):82-5. PubMed ID: 3891123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyvadic in advanced soft tissue sarcoma: a randomized study comparing two schedules. A study of the EORTC Soft Tissue and Bone Sarcoma Group.
    Pinedo HM; Bramwell VH; Mouridsen HT; Somers R; Vendrik CP; Santoro A; Buesa J; Wagener T; van Oosterom AT; van Unnik JA
    Cancer; 1984 May; 53(9):1825-32. PubMed ID: 6367947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of advanced soft tissue sarcomas with a modified CYVADIC protocol.
    Pfeffer MR; Sulkes A; Biran S
    Oncology; 1984; 41(5):308-13. PubMed ID: 6548004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternatives to CYVADIC-combination therapy of soft tissue sarcomas.
    Hartlapp JH; Münch HJ; Illiger HJ; Wolter H; Jensen JC
    Klin Wochenschr; 1985 Nov; 63(22):1160-2. PubMed ID: 3841170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma--reduced local recurrence but no improvement in survival: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.
    Bramwell V; Rouesse J; Steward W; Santoro A; Schraffordt-Koops H; Buesa J; Ruka W; Priario J; Wagener T; Burgers M
    J Clin Oncol; 1994 Jun; 12(6):1137-49. PubMed ID: 8201375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclophosphamide, vincristine, adriamycin, and DTIC (CYVADIC) combination chemotherapy for the treatment of advanced sarcomas.
    Yap BS; Baker LH; Sinkovics JG; Rivkin SE; Bottomley R; Thigpen T; Burgess MA; Benjamin RS; Bodey GP
    Cancer Treat Rep; 1980 Jan; 64(1):93-8. PubMed ID: 7379060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternatives to CYVADIC combination therapy of soft tissue sarcomas.
    Hartlapp JH; Münch HJ; Illiger HJ; Wolter H; Jensen JC
    Cancer Chemother Pharmacol; 1986; 18 Suppl 2():S20-2. PubMed ID: 3815715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Palliative chemotherapy of adult soft tissue sarcomas with an association of cyclophosphamide-vincristine-adriamycine-dacarbazine (CYVADIC) (author's transl)].
    Bui B; Chauvergne J; Durand M; Brunet R
    Bull Cancer; 1981; 68(1):1-5. PubMed ID: 7225604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pilot study of an alternative CYVADIC + CBDCA protocol for adult soft tissue sarcoma as adjuvant chemotherapy].
    Matsumoto S; Kawaguchi N; Manabe J; Matsushita Y; Tanizawa T
    Gan To Kagaku Ryoho; 2002 Sep; 29(9):1571-4. PubMed ID: 12355942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ifosfamide, vincristine, doxorubicin and dacarbazine in adult patients with advanced soft-tissue sarcoma.
    Wiklund TA; Blomqvist CP; Virolainen M; Elomaa I
    Cancer Chemother Pharmacol; 1992; 30(2):100-4. PubMed ID: 1600589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CYVADIC regimen as a combination chemotherapy treatment option for advanced soft tissue sarcomas originating from the non-extremities.
    Nakano K; Motoi N; Takahashi S
    Intern Med; 2015; 54(2):187-93. PubMed ID: 25743010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact on progression-free survival of adjuvant cyclophosphamide, vincristine, doxorubicin (adriamycin), and dacarbazine (CYVADIC) chemotherapy for stage I uterine sarcoma. A prospective trial.
    Hempling RE; Piver MS; Baker TR
    Am J Clin Oncol; 1995 Aug; 18(4):282-6. PubMed ID: 7625366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination chemotherapy of advanced sarcomas in adults with "CYOMAD" (S7).
    Lynch G; Magill GB; Sordillo P; Golbey RB
    Cancer; 1982 Nov; 50(9):1724-7. PubMed ID: 6981452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: a randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.
    Santoro A; Tursz T; Mouridsen H; Verweij J; Steward W; Somers R; Buesa J; Casali P; Spooner D; Rankin E
    J Clin Oncol; 1995 Jul; 13(7):1537-45. PubMed ID: 7602342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination chemotherapy (CYVADIC) in metastatic soft tissue sarcomas.
    Karakousis CP; Rao U; Park HC
    Eur J Cancer Clin Oncol; 1982 Jan; 18(1):33-6. PubMed ID: 7200893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclophosphamide, vincristine, adriamycin, and dimethyl-triazeno imidazole carboxamide (CYVADIC) for sarcomas of the female genital tract.
    Piver MS; DeEulis TG; Lele SB; Barlow JJ
    Gynecol Oncol; 1982 Dec; 14(3):319-23. PubMed ID: 6897542
    [No Abstract]   [Full Text] [Related]  

  • 18. [Adjuvant chemotherapy of soft tissue sarcoma].
    Shinohara N; Yokoyama K
    Gan To Kagaku Ryoho; 1990 Feb; 17(2):198-204. PubMed ID: 2301950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Primary chemotherapy in soft tissue sarcomas considered inoperable].
    Rouëssé J; Le Chevalier T; Contesso G; Sarrazin D; Amiel JL; Sevin D; Carde P; Génin J
    Sem Hop; 1983 May; 59(19):1441-4. PubMed ID: 6310758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclophosphamide, adriamycin, DTIC and vincristine with methotrexate in the treatment of advanced soft tissue sarcomas.
    Pfeffer MR; Sulkes A; Biran S
    Isr J Med Sci; 1988; 24(9-10):599-603. PubMed ID: 3204008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.